Tag: Monoclonal antibody

spot_img
MEDICINE

Hympavzi (marstacimab): New Treatment for Hemophilia

SCIEU Team -
On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...
MEDICINE

Lecanemab for Early Alzheimer’s Disease approved in the UK but refused in EU 

Umesh Prasad -
Monoclonal antibodies (mAbs) lecanemab and donanemab have been approved for the treatment of early Alzheimer’s disease in the UK and USA respectively while lecanemab...
COVID-19

‘‘A living WHO guideline on drugs for COVID-19’’: The Eighth version (Seventh update) Released

SCIEU Team -
The eighth version (seventh update) of a living guideline is released. It replaces earlier versions. The latest update includes a strong recommendation for the...
COVID-19

Sotrovimab Approval in the UK: A Monoclonal Antibody Effective Against Omicron, may work for Future Variants as well

SCIEU Team -
Sotrovimab, a monoclonal antibody already approved for mild to moderate COVID-19 in several countries gets approval by MHRA in the UK. This antibody was intelligently designed...
COVID-19

COVID-19: ‘Neutralising Antibody’ Trials Begins in the UK

Umesh Prasad -
University College London Hospitals (UCLH) has announced neutralising antibody trial against COVID-19. The announcement on 25 December 2020 says ‘’UCLH doses first patient in...
COVID-19

New Strains of SARS-CoV-2 (the virus responsible for COVID-19): Could ‘Neutralising Antibodies’ Approach be Answer to Rapid Mutation?

Umesh Prasad -
Several new strains of the virus have emerged since the pandemic began. New variants were reported as early as February 2020. The current variant...
COVID-19

Monoclonal Antibodies and Protein Based Drugs Could be Used to Treat COVID-19 Patients

Rajeev Soni -
Existing biologics such as Canakinumab (monoclonal antibody), Anakinra (monoclonal antibody) and Rilonacept (fusion protein) can be exploited as therapeutics that restrain inflammation in COVID-19...
MEDICINE

New Hope for Attacking the Deadliest Form of Malaria

SCIEU Team -
Researchers have isolated CIS43, a human antibody that can effectively prevent the deadliest malaria caused by the parasite Plasmodium falciparum. Malaria is one of...

Stay in touch:

86,344FansLike
41,696FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

MEDICINE

Daraxonrasib Approved for Pancreatic Cancer

0
Daraxonrasib (Rasonque by Revolution Medicines, Inc.), an inhibitor of...
EARTH SCIENCE

Glacial Collapse Led to Seismic Event in Nepal 

0
The magnitude 5.2 seismic event recorded near the border...
ASTRONOMY & SPACE SCIENCE

Significance of Nancy Grace Roman Space Telescope

0
Nancy Grace Roman Space Telescope (commonly referred to as...
ASTRONOMY & SPACE SCIENCE

NASA Invites ISRO to Join Moon Base Programme

0
NASA has invited ISRO (Indian Space Research Organisation) to...
ASTRONOMY & SPACE SCIENCE

2026 Total Solar Eclipse

0
On 12 August 2026, a total solar eclipse was...